HIV-1 vs. HIV-2: Key Differences in Virulence, Progression, and Complications

HIV-1 and HIV-2 are two distinct types of the human immunodeficiency virus. While both can lead to AIDS, they differ significantly in geographic distribution, virulence, and disease progression.

HIV-1: Global Predominant Strain

Acute Infection

  • Fever, rash, sore throat, muscle aches, fatigue, swollen lymph nodes

Chronic Infection

  • Weight loss, fatigue, night sweats, diarrhea, thrush, pneumonia, opportunistic infections

Complications

  • Neurological: Dementia, neuropathy, stroke
  • Cardiovascular: Heart disease, stroke, peripheral artery disease
  • Kidney: HIV-associated nephropathy, kidney failure
  • Cancer: Kaposi's sarcoma, non-Hodgkin lymphoma, cervical cancer

HIV-2: Less Virulent, Slower Progression

Acute Infection

  • Usually milder than HIV-1; may include fever, rash, sore throat, muscle aches, fatigue

Chronic Infection

  • Similar to HIV-1 but typically progresses more slowly

Complications

  • Neurological, cardiovascular, kidney complications, and cancers are less common than with HIV-1.

Key Differences Summary

  • Geography: HIV-1 worldwide; HIV-2 concentrated in West Africa.
  • Virulence: HIV-2 has lower plasma viral loads, slower CD4 decline, lower transmission efficiency.
  • Treatment: HIV-2 is intrinsically resistant to NNRTIs (efavirenz, nevirapine); protease inhibitor and integrase inhibitor regimens preferred.

Overall: HIV-2 is generally less virulent than HIV-1, but it can still cause serious illness and death. Accurate typing guides appropriate therapy.

HIV & AIDS - Related Articles